BRAF V600E as an accurate marker to complement fine needle aspiration (FNA) cytology in the guidance of thyroid surgery in the Chinese population: evidence from over 1000 consecutive FNAs with follow-up.

Abstract excerpt

BACKGROUND: Currently, several commercial molecular tests have been developed for reclassifying thyroid nodules with indeterminate fine needle aspiration cytology. These tests are quite expensive and not available in China. Previous studies demonstrated a very high prevalence of the BRAF V600E mutation in Asian people. A high incidence may result in a robust sensitivity. We conducted this study to determine the...

Topics

Join the communities discussing this publication.

• Asian People
• Biomarkers, Tumor
• Biopsy, Fine-Needle
• Follow-Up Studies
• Proto-Oncogene Proteins B-raf